1 year return (CAGR)
133.23%
Protagonist Therapeutics Inc Exchange (NASDAQ, USD)
PTGX
145.07
+0.09 (+0.06%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
100.87%
5 year return (CAGR)
26.34%
10 year return (CAGR)
27.88%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
9.39B
Price/Sales
33.29
Ent value
9.01B
Price/Book
11.15
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
113.22
PEG
-
Forward P/E
-
EPS growth
1.26%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 144.64 |
| Daily high | 147.71 |
| Daily low | 144.57 |
| Daily Volume | 802K |
| All-time high | 158.62 |
| 1y analyst estimate | 174.69 |
| Beta | 1.79 |
| EPS (TTM) | 1.17 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 18 Mar 2026 |
Downside potential
Loading...
Downside potential data
| PTGX | S&P500 | |
| Current price drop from All-time high | -8.54% | -0.58% |
| Highest price drop | -85.79% | -56.47% |
| Date of highest drop | 13 Jun 2022 | 9 Mar 2009 |
| Avg drop from high | -39.65% | -10.68% |
| Avg time to new high | 25 days | 12 days |
| Max time to new high | 1055 days | 1805 days |
News
